A traditional Chinese herbal antilithic formula, Wulingsan, effectively prevents the renal deposition of calcium oxalate crystal in ethylene glycol-fed rats

Urological Research

Volumn 36, Issue 1, 2008, Pages 17-24

  Tsai, Chou Huang ^a   Chen, Yu Cheng ^a,b   Chen, Lieh Der ^a   Pan, Tien Chien ^a,c   Ho, Chien Yi ^a,d   Lai, Ming Tsung ^e   Tsai, Fuu Jen ^a,f   Chen, Wen Chi ^a,d  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^c CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^e CHINA MEDICAL UNIVERSITY   (Taiwan)

^f ASIA UNIVERSITY   (Taiwan)

Author keywords

Calcium oxalate; Ethylene glycol; Traditional Chinese medicine; Urinary stone; Wulingsan

Indexed keywords

CALCIUM; CALCIUM OXALATE; CHINESE DRUG; ETHYLENE GLYCOL; PHOSPHORUS; PLACEBO; PLANT EXTRACT; STARCH; UNCLASSIFIED DRUG; WULINGSAN EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CALCIUM OXALATE STONE; CHINESE HERB; CHINESE MEDICINE; COMPUTER PROGRAM; CONTROLLED STUDY; DRUG MEGADOSE; HISTOLOGY; KIDNEY CALCIFICATION; KIDNEY MASS; KIDNEY TUBULE DAMAGE; MALE; MICROSCOPY; NONHUMAN; PRIORITY JOURNAL; RAT; SPRAGUE DAWLEY RAT; URINALYSIS;

ANIMALS; CALCIUM OXALATE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUGS, CHINESE HERBAL; ETHYLENE GLYCOL; IMAGE PROCESSING, COMPUTER-ASSISTED; KIDNEY; MALE; NEPHROCALCINOSIS; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; URINARY CALCULI;

EID: 38849189282     PISSN: 03005623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00240-007-0122-4     Document Type: Article

References (36)

1. http://210.69.214.131:/webdata/AttachFiles/Attach_8327_2_94_css.pdf
2. http://210.69.214.131:/webdata/AttachFiles/Attach_2493_1_2-2-4.pdf
3. Ho SZ, Kuo HC (2002) Pathogenesis and epidemiology of urolithiasis. Tzu Chin Med J 14:337-346
4. Menon M, Resnick MI (2002) Urinary lithiasis: etiology, diagnosis, and medical management. In: Walsh PC, Retik AB, Vaughan ED Jr., Wein AJ (eds) Campbell's urology. 8th ed. WB Saunders, Philadelphia
5. Lee YH, Huang WC, Tsai JY (2002) Epidemiological studies on the prevalence of upper urinary calculi in Taiwan. Urol Int 68:172-177
6. Kim HH, Jo MK, Kwak C, Park SK, Yoo KY, Kang D, Lee C (2002) Prevalence and epidemiologic characteristics of urolithiasis in Seoul, Korea. Urology 59:517-521
7. Yoshida O, Terai A, Ohkawa T, Okada Y (1999) National trend of the incidence of urolithiasis in Japan from 1965 to 1995. Kidney Int 56:1899-1904
8. http://en.wikipedia.org/wiki/Taiwan#Environment_and_pollution
9. http://en.wikipedia.org/wiki/ List_of_countries_by_population_density#_note-cia
10. Cao ZG, Liu JH, Zhou SW (2004) Effect of alisma orientalis extract on renal stone formation and the expression of inter-alpha-trypsin inhibitor in rat urolithiasis model. Chin J Exp Surg 21:295-297
11. Liu QL, Sato S, Kishikawa T (2001) Effectiveness of a traditional Chinese medicine, Wulingsan, in suppressing the development of nephrocalcinosis induced by a high phosphorus diet in young rats. Med Electron Microsc 34: 103-114
12. Hattori T, Hayashi K, Nagao T (1992) Studies on antinephritic effects of plant components(3): effect of pachyman, a main component of Poria cocos Wolf on original-type anti-GBM nephritis in rats and its mechanisms. Jpn J Pharmacol 59:89-96
13. Bensky D, Barolet R (eds) (1990) Chinese herbal medicine: Formulas & Strategies. Eastland, Seatle, Washington
14. Chen YC, Ho CY, Chen LD, Hsu SF, Chen WC (2007) Wu-Ling-San formula inhibits the crystallization of calcium oxalate in vitro. Am J Chin Med 35:533-541
15. Nelde HJ, Bichler KH, Strohmaier WL (1988) Nephrocalcinosis in the kidney of the rat on atherogenic diet and the efffect of calcium antagonists (nifedipine). In: Bichler KN, Strohmaier WL (eds) Nephrocalcinosis calcium antagonists and kidney, Springer-Verlag, Berlin pp 113-125
16. Lee YH, Chang LS, Chen MT (1991) Characterization of ethylene glycol induced urolithiasis modle in rats. J Urol ROC 2:518-524
17. Lee YH, Huang WC, Chiang H (1992) Determinant role of testosterone in the pathogenesis of urolithiasis in rats. J Urol 147:1134-1138
18. Lee YH, Tsai JY, Huang JK (2000) Combined use of 30% lactose rich diet and 1% ethylene glycol: a new animal model for study of urolithiasis. J Urol ROC 11:149-154
19. Leth PM, Gregersen M (2005) Ethylene glycol poisoing. Forensic Sci Int 155:179-184
20. Green ML, Hatch M, Freel RW (2005) Ethylene glycol induces hyperoxaluria without metabolic acidosis in rats. Am J Physiol Renal Physiol 289:F536-F543
21. Selvam R, Kalaiselvi P, Govindaraj A (2001) Effect of A. Lanata leaf extract and Vediuppu chunnam on the urinary risk factors of calcium oxalate urolithiasis during experimental hyperoxaluria. Pharmacol Res 43:89-92
22. Das I, Gupta SK, Ansari SA (2005) In vitro inhibition and dissolution of calcium oxalate by edible plant Trianthema monogyna and pulse Macrotyloma uniflorum extracts. J Cryst Growth 273:546-554
23. Viel TA, Domingos CD, Monteriro APS (1999) Evaluation of the antiurolithiatic activity of the extract of Costus spiralis Roscoe in rats. J Ethnopharmacol 66:193-198
24. Gohel MDI, Wong SP (2006) Chinese herbal medicines and their efficacy in treating renal stones. Urol Res 34:365-372
25. Cao ZG, Liu JH, Zhou SW (2004) The effect of the active constituents of Alisma orientalis on renal stone formation and bikunin expression in rat urolithiasis model. Matl Med J China 84:1276-1279
26. Suzuki K, Kawamura K, Tsugawa R (1999) Formation and growth inhibition of calcium oxalate crystals by Takusha (Alismatis rhizoma). Scanning Microsc 13:183-189
27. Yin CP, Liu JH, Zhang YS (1997) Effects of Alisma orientalis Juzep on calcium oxalate crystallization in vitro and calcium oxalate renal stone in rats. Acta Univ Med Tongji 26:99-101
28. Wang SY, Deng CQ, Shi ZL (2003) Influcence of Rhizoma alismatis on inhibition of renal stone formation. J Guangzhou Univ Tradit Chin Med 20:294-296
29. Yasui T, Fujita K, Sato M (1999) The effect of takusha, a kampo medicine, on renal stone formation and osteopontin expression in a rat urolithiasis model. Urol Res 27:194-199
30. Yashimura K, Miake O, Okuyama A (1998) Effect of chorei-to and gorei-san on calcium oxalate crystallization in human urine. Hinyokika Kiyo 44:13-16
31. Wesson JA, Johnson RJ, Mazzali M (2003) Osteopontin is a critical inhibitor of Calcium oxalate crystal formation and retension in renal tubules. J Am Soc Nephrol 14:139-147
32. Grover PK, Dogra SC, Davidson BP (2000) The prothrombin gene is expressed in the rat kidney: implications for urolithiasis research. Eur J Biochem 267:61-67
33. Kumar V, Lieske JC (2006) Protein regulation of intrarenal crystallization. Curr Opin Nephrol Hypertens 15:374-380
34. Umekawa T, Chegini N, Khan SR (2003) Increase expression of monocyte chemoattractant protein-1(MCP-1) by renal epithelial cells in culture on exposure to calcium oxalate, phosphate and uric acid crystals. Nephrol Dial Transplant 18:664-669
35. Umekawa T, Hatanaka Y, Kurita T (2004) Effect of angiotensinII receptor blocakge on osteoponton expression and calcium oxalate crystal deposition in rat kidneys. J Am Soc Nephrol 15:653-644
36. Coe FC, Evan A, Worcester E (2005) Kidney stone disease. J Clin Invest 115:2598-2608